| Bioactivity | Pristinamycin, produced by Streptomyces pristinaespiralis, is an orally active streptogramin-like antibiotic consisting of two chemically unrelated components: Pristinamycin I (PI) and Pristinamycin II (PII). Pristinamycin is highly active against many antibiotic-resistant pathogens, particularly Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant S. aureus (VRSA) and Enterococcus faecium (VREF)[1]. | |||||||||
| Invitro | In-vitro studies show pristinamycin to inhibit Staphylococci and Streptococci, including Erythromycin highly-resistant organisms, at a concentration of less than or equal to 0.78 mg/l[2]. | |||||||||
| Name | Pristinamycin | |||||||||
| CAS | 270076-60-3 | |||||||||
| Formula | C73H89N11O17 | |||||||||
| Molar Mass | 1392.55 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
Pristinamycin
CAS: 270076-60-3 F: C73H89N11O17 W: 1392.55
Pristinamycin, produced by Streptomyces pristinaespiralis, is an orally active streptogramin-like antibiotic consisting
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.